checkAd

     105  0 Kommentare Allegro MicroSystems Reports Second Quarter 2024 Results

    – Net Sales Increased by 16% Year-over-Year –
    – GAAP & Non-GAAP EPS Increased 31% and 29% Respectively, Year-over-Year –
    – Automotive Sales Increased by 31% Year-over-Year Led by E-Mobility –

    MANCHESTER, N.H., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Allegro MicroSystems, Inc. (“Allegro” or the “Company”) (Nasdaq:ALGM), a global leader in power and sensing semiconductor solutions for motion control and energy efficient systems, today announced financial results for its second quarter which ended September 29, 2023.

    “We delivered second quarter net sales of $276 million dollars, up 16% year-over-year, driven by continued strength in Automotive, which grew 31% year-over-year. We also achieved record non-GAAP Diluted Earnings per Share of $0.40, an increase of 29% year-over-year,” said Vineet Nargolwala, President and CEO of Allegro MicroSystems. “E-Mobility (which is the electrification of vehicles and adoption of ADAS feature sets) continues to fuel Allegro’s growth. Sales into e-Mobility applications increased by nearly 60% year-over-year to 50% of second quarter Automotive sales, establishing a new milestone.”

    Second Quarter Financial Highlights:

    In thousands, except per share data   Three-Month Period Ended     Six-Month Period Ended  
        September 29,
    2023
        June 30,
    2023
        September 23,
    2022
        September 29,
    2023
        September 23,
    2022
     
        (Unaudited)     (Unaudited)     (Unaudited)     (Unaudited)     (Unaudited)  
    Net Sales                              
    Automotive   $ 205,936     $ 189,698     $ 157,398     $ 395,634     $ 307,047  
    Industrial     51,114       68,184       48,176       119,298       88,316  
    Other     18,459       20,411       32,092       38,870       60,056  
    Total net sales   $ 275,509     $ 278,293     $ 237,666     $ 553,802     $ 455,419  
    GAAP Financial Measures                              
    Gross margin %     57.9 %     56.8 %     55.5 %     57.3 %     55.0 %
    Operating margin %     26.5 %     25.4 %     25.2 %     25.9 %     16.4 %
    Diluted EPS   $ 0.34     $ 0.31     $ 0.26     $ 0.65     $ 0.32  
    Non-GAAP Financial Measures                              
    Gross margin %     58.3 %     57.8 %     56.2 %     58.1 %     55.6 %
    Operating margin %     31.3 %     30.8 %     27.9 %     31.0 %     26.6 %
    Diluted EPS   $ 0.40     $ 0.39     $ 0.31     $ 0.79     $ 0.55  
                                             

    Business Outlook

    For the third quarter ending December 29, 2023, and including two months of activity from the Crocus Technologies, Inc. acquisition which closed on October 31, 2023, the Company expects net sales to be in the range of $250 million to $260 million. The Company also estimates the following results on a non-GAAP basis:

    • Gross Margin is expected to be approximately 54%, reflecting lower distribution sales and the initial impact of Crocus
    • Operating Expenses are expected to decline 4% sequentially, and are anticipated to be approximately 28% of sales
    • Diluted Earnings per Share are expected to be in the range of $0.27 to $0.31

    For the two-month period for which Crocus is included in the Company’s third quarter results, it is expected to add approximately $5 million to net sales, $3.5 million to interest expense, and be $0.03 dilutive to EPS.

    Commenting on the outlook, Vineet Nargolwala said, “Our backlog remains robust. Our sales forecast reflects normal third quarter seasonality, lingering impacts from the UAW strike, heightened macroeconomic trends and elevated inventory levels in Industrial and Consumer markets. Over the mid and the long term, continued strong momentum in design wins (especially in our strategic focus areas of e-Mobility, Clean Energy and Automation) and deepening and expanding partnerships with leading OEMs reinforce our conviction in the target model of low double-digit sales growth and above 32% operating margin.”

    Allegro has not provided a reconciliation of its third fiscal quarter outlook for non-GAAP Gross Margin, non-GAAP Operating Expenses, non-GAAP Interest Expense and non-GAAP Diluted Earnings per Share because estimates of all of the reconciling items cannot be provided without unreasonable efforts. It is difficult to reasonably provide a forward-looking estimate between such forward-looking non-GAAP measures and the comparable forward-looking U.S. generally accepted accounting principles (“GAAP”) measures. Certain factors that are materially significant to Allegro’s ability to estimate these items are out of its control and/or cannot be reasonably predicted.

    Earnings Webcast

    A webcast will be held on Thursday, November 2, 2023 at 8:30 a.m., Eastern Time. Vineet Nargolwala, President and Chief Executive Officer, and Derek D’Antilio, Chief Financial Officer, will discuss Allegro’s business and financial results.

    The webcast will be available on the Investor Relations section of the Company’s website at investors.allegromicro.com. A recording of the webcast will be posted in the same location shortly after the call concludes and will be available for at least 90 days.

    About Allegro MicroSystems

    Allegro MicroSystems is a leading global designer, developer, fabless manufacturer and marketer of sensor integrated circuits (“ICs”) and application-specific analog power ICs enabling emerging technologies in the automotive and industrial markets. Allegro’s diverse product portfolio provides efficient and reliable solutions for the electrification of vehicles, automotive ADAS safety features, automation for Industry 4.0 and power saving technologies for data centers and green energy applications.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts contained in this press release including statements regarding our future results of operations and financial position, business strategy, prospective products and the plans and objectives of management for future operations, including, among others, statements regarding the liquidity, growth and profitability strategies and factors affecting our business are forward-looking statements. These statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.

    Without limiting the foregoing, in some cases, you can identify forward-looking statements by terms such as “aim,” “may,” “will,” “should,” “expect,” “exploring,” “plan,” “anticipate,” “could,” “intend,” “target,” “project,” “would,” “contemplate,” “believe,” “estimate,” “predict,” “potential,” “seek,” or “continue” or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words. No forward-looking statement is a guarantee of future results, performance, or achievements, and one should avoid placing undue reliance on such statements.

    Forward-looking statements are based on our management’s current expectations, beliefs and assumptions and on information currently available to us. Such beliefs and assumptions may or may not prove to be correct. Additionally, such forward-looking statements are subject to a number of known and unknown risks, uncertainties and assumptions, and actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors, including, but not limited to, those identified in Part II, Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and Part I, Item 1A. “Risk Factors” in our Annual Report on Form 10-K for the year ended March 31, 2023. These risks and uncertainties include, but are not limited to: downturns or volatility in general economic conditions; our ability to compete effectively, expand our market share and increase our net sales and profitability; our reliance on a limited number of third-party semiconductor wafer fabrication facilities and suppliers of other materials; our failure to adjust purchase commitments and inventory management based on changing market conditions or customer demand; shifts in our product mix or customer mix, which could negatively impact our gross margin; the risk that the expected benefits of acquisitions may not be realized or that integration of acquired businesses may not continue as rapidly as we anticipate; the cyclical nature of the analog semiconductor industry; any downturn or disruption in the automotive market; our ability to compensate for decreases in average selling prices of our products and increases in input costs; our ability to manage any sustained yield problems or other delays at our third-party wafer fabrication facilities or in the final assembly and test of our products; our ability to accurately predict our quarterly net sales and operating results; our ability to adjust our supply chain volume to account for changing market conditions and customer demand; our dependence on manufacturing operations in the Philippines; our reliance on distributors to generate sales; the effects of COVID-19 on our supply chain and customer demand; our ability to develop new product features or new products in a timely and cost-effective manner; our ability to manage growth; any slowdown in the growth of our end markets; the loss of one or more significant customers; our ability to meet customers’ quality requirements; uncertainties related to the design win process and our ability to recover design and development expenses and to generate timely or sufficient net sales or margins; changes in government trade policies, including the imposition of export restrictions and tariffs; our exposures to warranty claims, product liability claims and product recalls; our dependence on international customers and operations; the availability of rebates, tax credits and other financial incentives on end-user demands for certain products; risks, liabilities, costs and obligations related to governmental regulation and other legal obligations, including export control, privacy, data protection, information security, consumer protection, environmental and occupational health and safety, anti-corruption and anti-bribery, and trade controls; the volatility of currency exchange rates; our ability to raise capital to support our growth strategy; our indebtedness may limit our flexibility to operate our business; our ability to effectively manage our growth and to retain key and highly skilled personnel; our ability to protect our proprietary technology and inventions through patents or trade secrets; our ability to commercialize our products without infringing third-party intellectual property rights; disruptions or breaches of our information technology systems or those of our third-party service providers; our principal stockholders have substantial control over us; the inapplicability of the “corporate opportunity” doctrine to any director or stockholder who is not employed by us; anti-takeover provisions in our organizational documents and under the General Corporation Law of the State of Delaware; our inability to design, implement or maintain effective internal control over financial reporting; changes in tax rates or the adoption of new tax legislation; the negative impacts of sustained inflation on our business; disruptions in the banking and financial sector that limit our or our partners’ ability to access capital and borrowings; the physical, transition and litigation risks presented by climate change; and other events beyond our control. Moreover, we operate in an evolving environment. New risk factors and uncertainties may emerge from time to time, and it is not possible for management to predict all risk factors and uncertainties.

    You should read this press release and the documents that we reference completely and with the understanding that our actual future results may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements. All forward-looking statements speak only as of the date of this press release, and except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements, whether as a result of any new information, future events, changed circumstances or otherwise.

    This press release includes certain non-GAAP financial measures as defined by the Securities and Exchange Commission (“SEC”) rules. These non-GAAP financial measures are provided in addition to, and not as a substitute for or superior to measures of, financial performance prepared in accordance with GAAP. There are a number of limitations related to the use of these non-GAAP financial measures versus their nearest GAAP equivalents. For example, other companies may calculate non-GAAP financial measures differently or may use other measures to evaluate their performance, all of which could reduce the usefulness of the presented non-GAAP financial measures as tools for comparison.

    This press release may not be reproduced, forwarded to any person or published, in whole or in part.

    ALLEGRO MICROSYSTEMS, INC.
    CONSOLIDATED STATEMENT OF OPERATIONS
    (in thousands, except share and per share amounts)

        Three-Month Period Ended     Six-Month Period Ended  
        September 29,
    2023
        September 23,
    2022
        September 29,
    2023
        September 23,
    2022
     
        (Unaudited)     (Unaudited)     (Unaudited)     (Unaudited)  
    Net sales   $ 275,509     $ 237,666     $ 553,802     $ 455,419  
    Cost of goods sold     116,006       105,644       236,349       205,023  
    Gross profit     159,503       132,022       317,453       250,396  
    Operating expenses:                        
    Research and development     43,428       35,567       86,403       69,424  
    Selling, general and administrative     43,160       36,617       87,389       106,397  
    Total operating expenses     86,588       72,184       173,792       175,821  
    Operating income     72,915       59,838       143,661       74,575  
    Interest and other income (expense)     156       (752 )     (2,486 )     (3,241 )
    Income before income taxes     73,071       59,086       141,175       71,334  
    Income tax provision     7,400       8,438       14,615       10,403  
    Net income     65,671       50,648       126,560       60,931  
    Net income attributable to non-controlling interests     54       34       93       70  
    Net income attributable to Allegro MicroSystems, Inc.   $ 65,617     $ 50,614     $ 126,467     $ 60,861  
    Net income per common share attributable to Allegro MicroSystems, Inc.:                        
    Basic   $ 0.34     $ 0.26     $ 0.66     $ 0.32  
    Diluted   $ 0.34     $ 0.26     $ 0.65     $ 0.32  
    Weighted average shares outstanding:                        
    Basic     192,431,094       191,284,631       192,214,210       190,959,616  
    Diluted     195,100,855       192,639,576       195,055,495       192,654,097  
                                     

    Supplemental Schedule of Total Net Sales

    The following table summarizes total net sales by market within the Company’s unaudited consolidated statements of operations:

        Three-Month Period Ended   Change     Six-Month Period Ended   Change  
        September 29,
    2023
      September 23,
    2022
      Amount     %     September 29,
    2023
      September 23,
    2022
      Amount     %  
        (Dollars in thousands)     (Dollars in thousands)  
    Automotive   $ 205,936   $ 157,398   $ 48,538     31 %   $ 395,634   $ 307,047   $ 88,587     29 %
    Industrial     51,114     48,176     2,938     6 %     119,298     88,316     30,982     35 %
    Other     18,459     32,092     (13,633 )   (42 )%     38,870     60,056     (21,186 )   (35 )%
    Total net sales   $ 275,509   $ 237,666   $ 37,843     16 %   $ 553,802   $ 455,419   $ 98,383     22 %
                                                         

    ALLEGRO MICROSYSTEMS, INC.
    CONSOLIDATED BALANCE SHEETS
    (in thousands, except share and per share amounts)

        September 29,     March 31,  
        2023
    (Unaudited)
        2023  
    Assets            
    Current assets:            
    Cash and cash equivalents   $ 370,013     $ 351,576  
    Restricted cash     8,418       7,129  
    Trade accounts receivable, net     118,947       111,290  
    Trade and other accounts receivable due from related party     741       13,494  
    Inventories     173,089       151,301  
    Prepaid expenses and other current assets     39,938       27,289  
    Current portion of related party note receivable     3,750       3,750  
    Total current assets     714,896       665,829  
    Property, plant and equipment, net     312,047       263,099  
    Deferred income tax assets     68,385       50,359  
    Goodwill     27,707       27,691  
    Intangible assets, net     51,677       52,378  
    Related party note receivable, less current portion     6,563       8,438  
    Equity investment in related party     25,474       27,265  
    Other assets     78,188       86,096  
    Total assets   $ 1,284,937     $ 1,181,155  
    Liabilities, Non-Controlling Interests and Stockholders' Equity            
    Current liabilities:            
    Trade accounts payable   $ 62,603     $ 56,256  
    Amount due to related party     3,041       9,682  
    Accrued expenses and other current liabilities     68,597       99,387  
    Total current liabilities     134,241       165,325  
    Obligations due under Senior Secured Credit Facilities     25,000       25,000  
    Other long-term liabilities     27,408       24,015  
    Total liabilities     186,649       214,340  
    Commitments and contingencies            
    Stockholders' Equity:            
    Preferred stock            
    Common stock     1,925       1,918  
    Additional paid-in capital     683,891       674,179  
    Retained earnings     436,782       310,315  
    Accumulated other comprehensive loss     (25,509 )     (20,784 )
    Equity attributable to Allegro MicroSystems, Inc.     1,097,089       965,628  
    Non-controlling interests     1,199       1,187  
    Total stockholders' equity     1,098,288       966,815  
    Total liabilities, non-controlling interests and stockholders' equity   $ 1,284,937     $ 1,181,155  
                     

    ALLEGRO MICROSYSTEMS, INC.
    CONSOLIDATED STATEMENTS OF CASH FLOWS
    (in thousands)

        Three Months Ended     Six Months Ended  
        September 29,
    2023
        September 23,
    2022
        September 29,
    2023
        September 23,
    2022
     
        (Unaudited)     (Unaudited)     (Unaudited)     (Unaudited)  
    Cash flows from operating activities:                        
    Net income   $ 65,671     $ 50,648     $ 126,560     $ 60,931  
    Adjustments to reconcile net income to net cash provided by operating activities:                        
    Depreciation and amortization     15,080       12,207       29,353       24,125  
    Amortization of deferred financing costs     73       25       107       49  
    Deferred income taxes     (9,772 )     (8,647 )     (18,134 )     (16,431 )
    Stock-based compensation     10,877       8,204       21,919       42,340  
    Loss on disposal of assets     43       253       43       250  
    Change in fair value of contingent consideration           (2,500 )           (2,700 )
    Provisions for inventory and receivables reserves     4,239       (2,408 )     9,422       232  
    Change in fair value of marketable securities     (72 )     (28 )     3,579       3,458  
    Changes in operating assets and liabilities:                        
    Trade accounts receivable     2,676       10,238       (7,645 )     5,520  
    Accounts receivable - other     1,052       (168 )     (369 )     2,546  
    Inventories     (3,274 )     (12,440 )     (31,221 )     (17,328 )
    Prepaid expenses and other assets     (7,305 )     3,632       (16,084 )     (9,470 )
    Trade accounts payable     (15,736 )     4,853       2,695       8,928  
    Due (from) to related party     (3,990 )     (2,414 )     6,112       (5,681 )
    Accrued expenses and other current and long-term liabilities     (12,832 )     (6,204 )     (29,944 )     (4,965 )
    Net cash provided by operating activities     46,730       55,251       96,393       91,804  
    Cash flows from investing activities:                        
    Purchases of property, plant and equipment     (31,191 )     (20,831 )     (76,101 )     (35,220 )
    Acquisition of business, net of cash acquired           (19,728 )           (19,728 )
    Proceeds from sale of marketable securities     6,204             16,175        
    Net cash used in investing activities     (24,987 )     (40,559 )     (59,926 )     (54,948 )
    Cash flows from financing activities:                        
    Loans made to related party           (7,500 )           (7,500 )
    Loan made to affiliate     (4,000 )           (4,000 )      
    Receipts on related party note receivable     937       468       1,875       937  
    Payments for taxes related to net share settlement of equity awards     (1,669 )           (14,091 )     (9,606 )
    Proceeds from issuance of common stock under employee stock purchase plan           1,573       1,899       1,573  
    Payment for debt issuance costs                 (1,450 )      
    Net cash used in by financing activities     (4,732 )     (5,459 )     (15,767 )     (14,596 )
    Effect of exchange rate changes on cash and cash equivalents and restricted cash     (901 )     (2,223 )     (974 )     (8,777 )
    Net increase in cash and cash equivalents and restricted cash     16,110       7,010       19,726       13,483  
    Cash and cash equivalents and Restricted cash at beginning of period     362,321       296,272       358,705       289,799  
    Cash and cash equivalents and restricted cash at end of period:   $ 378,431     $ 303,282     $ 378,431     $ 303,282  
                                     

    Non-GAAP Financial Measures

    In addition to the measures presented in our consolidated financial statements, we regularly review other measures, defined as non-GAAP financial measures by the SEC, to evaluate our business, measure our performance, identify trends, prepare financial forecasts and make strategic decisions. The key measures we consider are non-GAAP Gross Profit, non-GAAP Gross Margin, non-GAAP Operating Expenses, non-GAAP Operating Income, non-GAAP Operating Margin, non-GAAP Profit before Tax, non-GAAP Provision for Income Tax, non-GAAP Net Income and non-GAAP Basic and Diluted Earnings per Share, EBITDA, Adjusted EBITDA and Adjusted EBITDA margin (collectively, the “Non-GAAP Financial Measures”). These Non-GAAP Financial Measures provide supplemental information regarding our operating performance on a non-GAAP basis that excludes certain gains, losses and charges of a non-cash nature or that occur relatively infrequently and/or that management considers to be unrelated to our core operations, and in the case of non-GAAP Provision for Income Tax, management believes that this non-GAAP measure of income taxes provides it with the ability to evaluate the non-GAAP Provision for Income Taxes across different reporting periods on a consistent basis, independent of special items and discrete items, which may vary in size and frequency. These Non-GAAP Financial Measures are used by both management and our board of directors, together with the comparable GAAP information, in evaluating our current performance and planning our future business activities.

    The Non-GAAP Financial Measures are supplemental measures of our performance that are neither required by, nor presented in accordance with GAAP. These Non-GAAP Financial Measures should not be considered as substitutes for GAAP financial measures such as gross profit, gross margin, net income or any other performance measures derived in accordance with GAAP. Also, in the future we may incur expenses or charges such as those being adjusted in the calculation of these Non-GAAP Financial Measures. Our presentation of these Non-GAAP Financial Measures should not be construed as an inference that future results will be unaffected by unusual or nonrecurring items. These non-GAAP Financial Measures exclude costs related to acquisition and related integration expenses, amortization of acquired intangible assets, stock-based compensation, restructuring actions, related party activities and other non-operational costs.

    Non-GAAP Provision for Income Tax

    In calculating non-GAAP Provision for Income Tax, we have added back the following to GAAP Income Tax Provision:

    • Tax effect of adjustments to GAAP results—Represents the estimated income tax effect of the adjustments to non-GAAP Profit before Tax described above and elimination of discrete tax adjustments.
        Three-Month Period Ended     Six-Month Period Ended  
        September 29,
    2023
        June 30,
    2023
        September 23,
    2022
        September 29,
    2023
        September 23,
    2022
     
        (Dollars in thousands)     (Dollars in thousands)  
    Reconciliation of Non-GAAP Gross Profit                              
                                   
    GAAP Gross Profit   $ 159,503     $ 157,950     $ 132,022     $ 317,453     $ 250,396  
    Non-GAAP adjustments                              
    Purchased intangible amortization     273       402       378       675       651  
    Stock-based compensation     946       2,606       1,124       3,552       1,956  
    Total Non-GAAP Adjustments   $ 1,219     $ 3,008     $ 1,502     $ 4,227     $ 2,607  
                                   
    Non-GAAP Gross Profit   $ 160,722     $ 160,958     $ 133,524     $ 321,680     $ 253,003  
    Non-GAAP Gross Margin (% of net sales)     58.3 %     57.8 %     56.2 %     58.1 %     55.6 %
                                             


        Three-Month Period Ended     Six-Month Period Ended  
        September 29,
    2023
        June 30,
    2023
        September 23,
    2022
        September 29,
    2023
        September 23,
    2022
     
        (Dollars in thousands)     (Dollars in thousands)  
    Reconciliation of Non-GAAP Operating Expenses                              
                                   
    GAAP Operating Expenses   $ 86,588     $ 87,204     $ 72,184     $ 173,792     $ 175,821  
                                   
    Research and Development Expenses                              
    GAAP Research and Development Expenses     43,428       42,975       35,567       86,403       69,424  
    Non-GAAP adjustments                              
    Transaction-related costs     2       7       201       9       403  
    Stock-based compensation     3,602       2,868       1,711       6,470       2,839  
    Non-GAAP Research and Development Expenses     39,824       40,100       33,655       79,924       66,182  
                                   
    Selling, General and Administrative Expenses                              
    GAAP Selling, General and Administrative Expenses     43,160       44,229       39,117       87,389       109,097  
    Non-GAAP adjustments                              
    Transaction-related costs     1,804       3,072       63       4,876       1,660  
    Purchased intangible amortization     357       358       23       715       45  
    Restructuring costs                 90             4,372  
    Stock-based compensation     6,329       5,568       5,369       11,897       37,545  
    Other costs     100                   100        
    Non-GAAP Selling, General and Administrative Expenses     34,570       35,231       33,572       69,801       65,475  
                                   
    Change in fair value of contingent consideration                 (2,500 )           (2,700 )
                                   
    Total Non-GAAP Adjustments     12,194       11,873       4,957       24,067       44,164  
                                   
    Non-GAAP Operating Expenses   $ 74,394     $ 75,331     $ 67,227     $ 149,725     $ 131,657  
                                             


        Three-Month Period Ended     Six-Month Period Ended  
        September 29,
    2023
        June 30,
    2023
        September 23,
    2022
        September 29,
    2023
        September 23,
    2022
     
        (Dollars in thousands)     (Dollars in thousands)  
    Reconciliation of Non-GAAP Operating Income                              
                                   
    GAAP Operating Income   $ 72,915     $ 70,746     $ 59,838     $ 143,661     $ 74,575  
                                   
    Transaction-related costs     1,806       3,079       (2,236 )     4,885       (637 )
    Purchased intangible amortization     630       760       401       1,390       696  
    Restructuring costs                 90             4,372  
    Stock-based compensation     10,877       11,042       8,204       21,919       42,340  
    Other costs     100                   100        
    Total Non-GAAP Adjustments   $ 13,413     $ 14,881     $ 6,459     $ 28,294     $ 46,771  
                                   
    Non-GAAP Operating Income   $ 86,328     $ 85,627     $ 66,297     $ 171,955     $ 121,346  
    Non-GAAP Operating Margin (% of net sales)     31.3 %     30.8 %     27.9 %     31.0 %     26.6 %
                                             


        Three-Month Period Ended     Six-Month Period Ended  
        September 29,
    2023
        June 30,
    2023
        September 23,
    2022
        September 29,
    2023
        September 23,
    2022
     
        (Dollars in thousands)     (Dollars in thousands)  
    Reconciliation of EBITDA and Adjusted EBITDA                              
                                   
    GAAP Net Income   $ 65,671     $ 60,889     $ 50,648     $ 126,560     $ 60,931  
                                   
    Interest expense     978       769       531       1,747       968  
    Interest income     (1,070 )     (843 )     (467 )     (1,913 )     (784 )
    Income tax provision     7,400       7,215       8,438       14,615       10,403  
    Depreciation & amortization     15,145       14,273       12,207       29,418       24,125  
    EBITDA   $ 88,124     $ 82,303     $ 71,357     $ 170,427     $ 95,643  
                                   
    Transaction-related costs     1,806       3,079       (2,236 )     4,885       (637 )
    Restructuring costs                 90             4,372  
    Stock-based compensation     10,877       11,042       8,204       21,919       42,340  
    Other costs     1,301       4,589       988       5,890       3,411  
    Adjusted EBITDA   $ 102,108     $ 101,013     $ 78,403     $ 203,121     $ 145,129  
    Adjusted EBITDA Margin (% of net sales)     37.1 %     36.3 %     33.0 %     36.7 %     31.9 %
                                             


        Three-Month Period Ended     Six-Month Period Ended  
        September 29,
    2023
        June 30,
    2023
        September 23,
    2022
        September 29,
    2023
        September 23,
    2022
     
        (Dollars in thousands)     (Dollars in thousands)  
    Reconciliation of Non-GAAP Profit before Tax                              
                                   
    GAAP Income before Income Taxes   $ 73,071     $ 68,104     $ 59,086     $ 141,175     $ 71,334  
                                   
    Transaction-related costs     1,806       3,079       (2,236 )     4,885       (637 )
    Purchased intangible amortization     630       760       401       1,390       696  
    Restructuring costs                 90             4,372  
    Stock-based compensation     10,877       11,042       8,204       21,919       42,340  
    Other costs     1,301       4,589       988       5,890       3,411  
    Total Non-GAAP Adjustments   $ 14,614     $ 19,470     $ 7,447     $ 34,084     $ 50,182  
                                   
    Non-GAAP Profit before Tax   $ 87,685     $ 87,574     $ 66,533     $ 175,259     $ 121,516  
                                             


        Three-Month Period Ended     Six-Month Period Ended  
        September 29,
    2023
        June 30,
    2023
        September 23,
    2022
        September 29,
    2023
        September 23,
    2022
     
        (Dollars in thousands)     (Dollars in thousands)  
    Reconciliation of Non-GAAP Provision for Income Taxes                              
                                   
    GAAP Income Tax Provision   $ 7,400     $ 7,215     $ 8,438     $ 14,615     $ 10,403  
    GAAP effective tax rate     10.1 %     10.6 %     14.3 %     10.4 %     14.6 %
                                   
    Tax effect of adjustments to GAAP results     2,554       3,826       (1,663 )     6,380       4,237  
                                   
    Non-GAAP Provision for Income Taxes   $ 9,954     $ 11,041     $ 6,775     $ 20,995     $ 14,640  
    Non-GAAP effective tax rate     11.4 %     12.6 %     10.2 %     12.0 %     12.0 %
                                             


        Three-Month Period Ended     Six-Month Period Ended  
        September 29,
    2023
        June 30,
    2023
        September 23,
    2022
        September 29,
    2023
        September 23,
    2022
     
        (Dollars in thousands)     (Dollars in thousands)  
    Reconciliation of Non-GAAP Net Income                              
                                   
    GAAP Net Income   $ 65,671     $ 60,889     $ 50,648     $ 126,560     $ 60,931  
    GAAP Basic Earnings per Share   $ 0.34     $ 0.32     $ 0.26     $ 0.66     $ 0.32  
    GAAP Diluted Earnings per Share   $ 0.34     $ 0.31     $ 0.26     $ 0.65     $ 0.32  
                                   
    Transaction-related costs     1,806       3,079       (2,236 )     4,885       (637 )
    Purchased intangible amortization     630       760       401       1,390       696  
    Restructuring costs                 90             4,372  
    Stock-based compensation     10,877       11,042       8,204       21,919       42,340  
    Other costs     1,301       4,589       988       5,890       3,411  
    Total Non-GAAP Adjustments     14,614       19,470       7,447       34,084       50,182  
    Tax effect of adjustments to GAAP results   $ (2,554 )   $ (3,826 )   $ 1,663     $ (6,380 )   $ (4,237 )
    Non-GAAP Net Income   $ 77,731     $ 76,533     $ 59,758     $ 154,264     $ 106,876  
    Basic weighted average common shares     192,431,094       191,997,330       191,284,631       192,214,210       190,959,616  
    Diluted weighted average common shares     195,100,855       194,991,906       192,639,576       195,055,495       192,654,097  
    Non-GAAP Basic Earnings per Share   $ 0.40     $ 0.40     $ 0.31     $ 0.80     $ 0.56  
    Non-GAAP Diluted Earnings per Share   $ 0.40     $ 0.39     $ 0.31     $ 0.79     $ 0.55  

    Investor Contact:
    Jalene Hoover
    VP of Investor Relations & Corporate Communications
    +1 (512) 751-6526
    jhoover@allegromicro.com 





    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    Allegro MicroSystems Reports Second Quarter 2024 Results – Net Sales Increased by 16% Year-over-Year –– GAAP & Non-GAAP EPS Increased 31% and 29% Respectively, Year-over-Year –– Automotive Sales Increased by 31% Year-over-Year Led by E-Mobility – MANCHESTER, N.H., Nov. 02, 2023 (GLOBE NEWSWIRE) - …